Published on in CHOP in the Media
Focusing on Juliet Belcher, an 8-year-old CHOP patient with a rare mitochondrial disease, the Philadelphia Inquirer highlights how CHOP researchers have identified a central signaling network that acts a “fuse box” in these energy disorders.
Published on in CHOP News
CHOP researchers identified a master network of signaling molecules in diverse mitochondrial diseases. Targeting this network in cells from patients suggests possible new treatments.
Published on in CHOP News
CHOP researchers’ new single-platform tool streamlines diagnoses of complicated multisystem disorders
Published on in CHOP News
Douglas Wallace, PhD, director of CHOP's Center for Mitochondrial and Epigenomic Medicine, will receive the $500,000 Gruber Foundation 2012 Genetics Prize for his pioneering mitochondrial research.
Published on in CHOP News
Results from a new animal study at The Children's Hospital of Philadelphia may point the way to treatment of rare metabolic disorders in humans.
Published on in CHOP News
Douglas C. Wallace, PhD, a pioneer and internationally prominent scientist in the field of human mitochondrial genetics, joined CHOP to help establish the Center of Mitochondrial and Epigenomic Medicine.
Published on in CHOP News
CHOP researchers reveal how mitochondrial gene defects impair respiration and other major life functions.